{
  "id": 18467267,
  "title": "Oxford spin-out Alethio Therapeutics raises €80.46 million Series A to advance targeted blood cancer therapies",
  "url": "https://urgent.news/2026/11/06/oxford-spin-out-alethio-therapeutics-raises-80-46-million-series-a-to",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-06T08:17:05.000Z",
  "source": {
    "name": "EU-Startups",
    "slug": "eu-startups",
    "url": "https://www.eu-startups.com/2026/11/oxford-spin-out-alethio-therapeutics-raises-e80-46-million-series-a-to-advance-targeted-blood-cancer-therapies/"
  },
  "original_language": "en",
  "account": "Oxford-based biotech Alethio Therapeutics has secured €80.46 million (£67 million) in Series A funding to develop targeted therapies for myeloproliferative neoplasms (MPNs). The round, co-led by Sofinnova Partners and RA Capital, is the company's first major financing. Alethio's approach targets disease-driving cells, aiming to modify the underlying disease rather than just manage symptoms. The funding will support the advancement of their lead candidate, ATX-011, a monoclonal antibody targeting G6B, as well as the development of additional MPN therapies. Alethio's co-founders, Professors Adam Mead and Beth Psaila, emphasized the potential of their approach to move patients beyond symptom management and toward true disease modification.",
  "summary": "Alethio Therapeutics (Alethio), an Abingdon-on-Thames-based biopharmaceutical company developing next-generation therapies for myeloproliferative neoplasms (MPNs), has announced the completion of an oversubscribed €80.46 million ($90 million/£67 million) Series A financing. The round was co-led by new investors Sofinnova Partners and RA Capital, alongside founding investor Oxford Science…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "BioPharma Dive",
        "title": "Alethio raises $90M to target rare blood cancers",
        "url": "https://urgent.news/2026/11/05/alethio-raises-90m-to-target-rare-blood-cancers",
        "published": "2026-11-05T08:00:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}